InvestorsHub Logo
Followers 1
Posts 298
Boards Moderated 0
Alias Born 11/16/2017

Re: SAMNOTSAMUEL post# 43488

Wednesday, 05/23/2018 12:37:07 PM

Wednesday, May 23, 2018 12:37:07 PM

Post# of 50157
You know as well as I do that there is no way Management initiated another FDA trial if they did not already have something lined up. No way they just thought that things have been going so well that they could afford to launch and maintain a second FDA trial with funding operations in this same manner. I think they wanted to make sure it ICC FDA trial would be official so would be considered a real asset that would need to be calculated into BO/Merger valuation. They have been going down a checklist of company issues and fixing as best as possible under the circumstances for a possible future acquirer to make company more attractive and increase value. I believe are now shopping it around. Hence all the PR. Management will no doubt get their golden parachute, or possibly even keep their positions in the transaction. But with a high level of oversite.
Like always nothing is guaranteed but defiantly a scenario that needs some serious consideration IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News